Nephron Pharmaceuticals Integrates STERIS VHP Biodecontamination System

March 22, 2021
STERIS Life Sciences

This case study examines the benefits and challenges Nephron Pharmaceuticals Corporation faced integrating a STERIS VHP® Biodecontamination system into their high-volume compounding facility.